CURX — Curanex Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Curanex Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash
Cash and Short Term Investments	0.002	0.074	0.149
Net Total Receivables	0.003	0	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.01	0.074	0.518
Total Assets	0.01	0.074	0.518
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0	0.014	0.015
Total Long Term Debt
Total Debt
Total Liabilities	0	0.014	0.015
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.01	0.06	0.503
Total Liabilities & Shareholders' Equity	0.01	0.074	0.518
Total Common Shares Outstanding